Heron Therapeutics Inc vs Teucrium Soybean Fund — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Teucrium Soybean Fund trades at $24.82. The key difference: Teucrium Soybean Fund is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | SOYB | |
|---|---|---|
Market Cap | $61.47M | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $1.49 | $26.28 |
52-Week Low | $0.32 | $21.46 |
Enterprise Value | $168.21M | — |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →